According to Amedisys's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.57. At the end of 2024 the company had a P/S ratio of 1.25.
Year | P/S ratio | Change |
---|---|---|
2024 | 1.25 | -9.54% |
2023 | 1.39 | 13.61% |
2022 | 1.22 | -48.78% |
2021 | 2.38 | -48.69% |
2020 | 4.65 | 68.61% |
2019 | 2.76 | 22.35% |
2018 | 2.25 | 91.07% |
2017 | 1.18 | 18.4% |
2016 | 0.9956 | -3.53% |
2015 | 1.03 | 26.07% |
2014 | 0.8186 | 114.6% |
2013 | 0.3814 | 58.57% |
2012 | 0.2406 | 9.02% |
2011 | 0.2206 | -63.18% |
2010 | 0.5992 | -33.81% |
2009 | 0.9053 | -3.67% |
2008 | 0.9398 | -48.73% |
2007 | 1.83 | 16.98% |
2006 | 1.57 | -10.85% |
2005 | 1.76 | -19.49% |
2004 | 2.18 | 72.36% |
2003 | 1.27 | 196.05% |
2002 | 0.4279 | -2.73% |
2001 | 0.4399 |